The 2022 Summit Program Committee is excited to review abstract submissions and curate a truly impeccable curriculum.
Submission Deadline: Friday, February 11, 2022
We must develop and test finance and access models to increase the uptake of PrEP among those with less or non-resources to access it. One model will not address all groups’ needs due to the diversity among the populations at risk of infection that will benefit from PrEP. These models entail drug and co-pays financing programs, rebates, clinical care, monitoring, adherence support, and initiatives that address social determinants and health disparities. These workshops will also engage attendees in the conversation on funding for community and clinical institutions to implement evidence-based models. Overall, this track looks at the implementation and evaluation of finance and access models and how they impact communities’ uptake in need.
The National HIV/AIDS Strategy (NHAS) provides a framework for the federal plan to end the HIV epidemic. The first version was published in 2010 under President Obama, and it was updated in 2015 and 2020.
While the early versions look at the details, the updated 2020 version looks at the broader aspects of the epidemic. The NHAS will require national coordination across federal agencies, community organizations, clinical providers, health departments, and key stakeholders. On this track, we will discuss the challenges and opportunities presented by the NHAS and its impact on the federal plan to end the HIV epidemic. In addition, workshops will focus on the essential role of biomedical HIV prevention on the NHAS and the ending of the HIV epidemic.
We need capacity building and training programs through the spectrum of stakeholders involved in making sure biomedical HIV prevention is understood and utilized by the populations in need. All involved require learning, from the person looking for PrEP or viral suppression to the community-based care and service providers, health clinic employees, doctors, and nurses. These education modalities include peer-education models, curriculum development, capacity building, collaborative learning, medical education, and online professional programs. This track will explore the importance of evidence-based capacity budling and culturally competent training and available to all stakeholders involved in HIV biomedical prevention, finance, psychosocial services, and clinical care.
If we are to be successful in implementing biomedical HIV prevention is essential to mobilize the communities most impacted and at risk of HIV infection. Community mobilization and evidence-based advocacy strategies are critical in putting the interests of its members to the fronts. Civil disobedience, community organizing, and advocacy for fair policies and funding has proven effective in promoting change. However, we should not underestimate the power of community and how it affects health outcomes. This track looks for workshops that display advocacy strategies, specifically those impacting biomedical HIV prevention access.
PrEP has been a game-changer since its introduction in 2012. Although it has not been accessible for communities of color, it has changed how gay and bisexual men who have sex with men (GBMSM) relate sexually. In addition, it is essential to recognize that gay men look for underground venues to find pleasure without judgment. Therefore, substance use, or how it is known underground, chemsex, becomes another critical topic that needs to be discussed. This track looks for workshops on sex positivity, chemsex, sex apps, and the underground.
There is little clinical information about the use of current biomedical HIV prevention methods on transgender and gender-nonconforming
(TGNC) people, especially TGNC people of color. However, according to the CDC, HIV prevalence rates among trans women of color are exceptionally high. More than half of all new transmissions among women and men of trans experience are African American. This track focuses on qualitative and quantitative data on TGNC people of color and biomedical prevention interventions (PrEP, PEP, TasP). The track will also discuss the barriers and facilitators for implementing programs and access to biomedical HIV prevention modalities among communities of TGNC experience.
There is little clinical information about current biomedical HIV prevention methods on cisgender women. However, according to the CDC, cisgender women comprise 19% of the new cases reported in the United States for 2018. This track focuses on qualitative and quantitative data on cisgender women and biomedical HIV prevention. The way will also discuss the barriers and facilitators for implementing programs and access to biomedical HIV prevention modalities for cisgender women.
This track will discuss practical strategies for making HIV biomedical prevention research more reflective of the communities most vulnerable to new HIV transmissions. In addition to sharing effective methods at diversifying HIV research, this track will focus on how CAP/CAB organizers can ensure meaningful participation from people living with HIV, especially queer, transgender, bisexual people of color (QTBIPOC) living with HIV.
This track will discuss current approaches to implementation science and evaluation related to biomedical HIV prevention and how they can inform evidence-based interventions to increase PrEP awareness and uptake.
Nota: Solo se aceptarán propuestas escritas en español.
Note: Only abstracts written in Spanish will be accepted.
El acceso de las comunidades hispanoparlantes a los avances de prevención biomédica del VIH, depende del acceso que estas poseen a la información y al cuidado médico. Es por eso que hemos diseñado esta área temática en español. En él se discutirán avances en las modalidades de PrEP y tratamiento, las barreras para accederlos y el rol de la comunidad y las organizaciones de base comunitaria en cerrar esta brecha. También se busca profundizar en el efecto desproporcional de la epidemia en personas latinas, y el impacto del racismo y el estatus migratorio.